Viking Therapeutics VKTX
NASDAQ VKTX
$26.38 -0.33 (-1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Operating Expenses (2014 - 2026)

Updated

Viking Therapeutics (VKTX) reported Operating Expenses of $132.6 million for Q2 2026, up 77.8% from $74.57 million a year earlier but down 19.2% from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Operating Expenses (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viking Therapeutics' Operating Expenses came in at $560.02 million, up 163.1% year-over-year; for FY2025, it was $393.34 million, up 160.6% from FY2024.

  • Operating Expenses has increased for ten consecutive years, with a five-year compound annual growth rate of 55.9% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $150.92 million in FY2024 (+49.7%), $100.83 million in FY2023 (+43.3%), $70.36 million in FY2022 (+26.4%) and $55.68 million in FY2021 (+30.5%).
  • Five-year quarterly Operating Expenses spans a low of $12.51 million in Q4 2021 and a high of $164.74 million in Q4 2025.
  • Year over year, Operating Expenses has now increased in each of the last 33 quarters, with growth averaging 121.7% over the last eight quarters.
  • Across the past five years, year-over-year growth in Operating Expenses ran from 11.0% in Q4 2021 to 256.3% in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $164.13 million (Q1 2026), $164.74 million (Q4 2025) and $98.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 Viking Therapeutics 3.07 Bn 545.20 Mn - 132.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132.60 Mn
Mar 31, 2026 164.13 Mn
Dec 31, 2025 164.74 Mn
Sep 30, 2025 98.56 Mn
Jun 30, 2025 74.57 Mn
Mar 31, 2025 55.47 Mn
Dec 31, 2024 46.24 Mn
Sep 30, 2024 36.56 Mn
Jun 30, 2024 34.05 Mn
Mar 31, 2024 34.07 Mn
Dec 31, 2023 29.29 Mn
Sep 30, 2023 27.27 Mn
Jun 30, 2023 23.74 Mn
Mar 31, 2023 20.54 Mn
Dec 31, 2022 20.28 Mn
Sep 30, 2022 16.20 Mn
Jun 30, 2022 17.63 Mn
Mar 31, 2022 16.25 Mn
Dec 31, 2021 12.51 Mn
Sep 30, 2021 13.40 Mn
API Access

Viking Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY